Drug company AbbVie has agreed to buy biotech ImmunoGen for $10.1 billion in a fresh bet on one of the most promising new technologies for attacking cancer.ImmunoGen develops cancer drugs called antibody-drug conjugates, or ADCs, which work like guided missiles delivering a toxic agent directly to tumors. The technology is among the hottest areas in the pharmaceutical industry. Recent advancements have spread its use to common kinds of cancer such as breast, spawning other multibillion deals.
- Forums
- ASX - By Stock
- ADC's on the move........
Drug company AbbVie has agreed to buy biotech ImmunoGen for...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $21.39K | 3.056M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 6182265 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 2976726 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 6182265 | 0.007 |
13 | 3563680 | 0.006 |
9 | 3719992 | 0.005 |
7 | 5449000 | 0.004 |
3 | 1829017 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 2976726 | 5 |
0.009 | 1929459 | 4 |
0.010 | 751500 | 3 |
0.011 | 1360000 | 4 |
0.012 | 372407 | 3 |
Last trade - 15.57pm 16/05/2024 (20 minute delay) ? |
|
|||||
Last
0.7¢ |
  |
Change
-0.001 ( 6.67 %) |
|||
Open | High | Low | Volume | ||
0.8¢ | 0.8¢ | 0.7¢ | 2373466 | ||
Last updated 15.35pm 16/05/2024 ? |
Featured News
PAB (ASX) Chart |